|
TTC28 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.673000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.178200E-01 |
| Normal-vs-Stage2 |
9.391400E-01 |
| Normal-vs-Stage3 |
2.182600E-01 |
| Normal-vs-Stage4 |
1.243570E-02 |
| Stage1-vs-Stage2 |
4.654400E-01 |
| Stage1-vs-Stage3 |
5.691000E-01 |
| Stage1-vs-Stage4 |
5.633700E-02 |
| Stage2-vs-Stage3 |
3.520800E-01 |
| Stage2-vs-Stage4 |
5.107700E-02 |
| Stage3-vs-Stage4 |
1.872800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.505800E-01 |
| Normal-vs-AfricanAmerican |
2.827600E-01 |
| Normal-vs-Asian |
2.830400E-02 |
| Caucasian-vs-AfricanAmerican |
4.073800E-01 |
| Caucasian-vs-Asian |
6.720500E-02 |
| AfricanAmerican-vs-Asian |
1.562620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.615200E-01 |
| Normal-vs-Female |
7.565200E-01 |
| Male-vs-Female |
5.124400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.453700E-02 |
| Normal-vs-Extreme_Weight |
8.759700E-02 |
| Normal-vs-Obese |
9.061600E-01 |
| Normal-vs-Extreme_Obese |
7.024400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.910000E-01 |
| Normal_Weight-vs-Obese |
3.148100E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.326590E-01 |
| Extreme_Weight-vs-Obese |
2.488500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.705200E-01 |
| Obese-vs-Extreme_Obese |
6.561400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.000800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.267600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.836780E-01 |
| Normal-vs-Age(81-100Yrs) |
9.001600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.908600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.881600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.699200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.715600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.139570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.999000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.602400E-01 |
| Normal-VS-Type2 PRCC |
3.798400E-02 |
| Normal-VS-KIRP CIMP |
8.516400E-03 |
| Normal-VS-Unclassified PRCC |
3.092400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.219200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.476700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.253200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.126000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.496600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.199820E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.161200E-01 |
| Normal-vs-N1 |
1.808000E-01 |
| Normal-vs-N2 |
8.379200E-01 |
| N0-vs-N1 |
6.311800E-01 |
| N0-vs-N2 |
7.322400E-01 |
| N1-vs-N2 |
6.461600E-01 |
|
|
